Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.81 |
| ▸ | CETP | P11597 | 4/20 | 0.57 |
| ▸ | SRC | P12931 | 1/20 | 0.53 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.49 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.45 |
| ▸ | ALPG | P10696 | 1/20 | 0.45 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alcohol SCHEMBL6037288 | 0.91 | TSHR (0.85) | TSHRCETPSRCAKR1C3FOLH1 | |
| SCHEMBL27908642 | 0.90 | TSHR (1.00) | TSHRCETPSRCAKR1C3FOLH1 | |
| SCHEMBL51316 | 0.90 | TSHR (1.00) | TSHRCETPSRCAKR1C3FOLH1 | |
| Hydrochloric Acid SCHEMBL10722992 | 0.88 | TSHR (0.96) | TSHRCETPSRCAKR1C3FOLH1 | |
| SCHEMBL11756554 | 0.88 | TSHR (0.96) | TSHRCETPSRCAKR1C3FOLH1 | |
| SCHEMBL28264490 | 0.88 | TSHR (0.96) | TSHRCETPSRCAKR1C3FOLH1 | |
| SCHEMBL4219700 | 0.88 | TSHR (0.96) | TSHRCETPSRCAKR1C3FOLH1 | |
| SCHEMBL9446520 | 0.88 | TSHR (0.96) | TSHRCETPSRCAKR1C3FOLH1 | |
| Ammonia Solution, Strong SCHEMBL7268743 | 0.88 | TSHR (0.96) | TSHRCETPSRCAKR1C3FOLH1 | |
| Phosphoric Acid SCHEMBL27741297 | 0.88 | TSHR (0.96) | TSHRCETPSRCAKR1C3FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2057217-B1 | BARIUM SULFATE-CONTAINING COMPOSITE | SACHTLEBEN CHEMIE GMBH (DE) | 2017-02-22 | — | — | EP | claimed |
| CN-103173884-B | A kind of halogen-free flame-retardant polypropylene fiber and preparation method thereof | 上海杰事杰新材料(集团)股份有限公司 | 2016-08-24 | — | — | CN | claimed |
| WO-2010149571-A1 | CHEMICAL FIBRE HAVING AN ADDITIVE FOR IMPROVING THE PHYSICAL PROPERTIES | SACHTLEBEN CHEMIE GMBH (DE) | 2010-12-29 | — | — | WO | claimed |
| US-7645334-B2 | Barium sulfate | SACHTLEBEN CHEMIE GMBH (DE) | 2010-01-12 | — | — | US | claimed |
| US-20090326114-A1 | BARIUM SULFATE-CONTAINING COMPOSITE | SACHTLEBEN CHEMIE GMBH (DE) | 2009-12-31 | — | — | US | claimed |
| US-20090318594-A1 | BARIUM SULFATE-CONTAINING COMPOSITE | SACHTLEBEN CHEMIE GMBH (DE) | 2009-12-24 | — | — | US | claimed |
| US-20080314291-A1 | Barium Sulfate | SACHTLEBEN CHEMIE GMBH (DE) | 2008-12-25 | — | — | US | claimed |
| EP-1989263-A1 | BARIUM SULPHATE | Sachtleben Chemie GmbH (DE) | 2008-11-12 | — | — | EP | claimed |
| WO-2007096385-A1 | BARIUM SULPHATE | SACHTLEBEN CHEMIE GMBH (DE) | 2007-08-30 | — | — | WO | claimed |
| WO-2024054618-A1 | METHODS FOR TREATMENT OF VIRAL INFECTIONS | GILEAD SCIENCES, INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| WO-2023239665-A1 | METHODS FOR TREATMENT OF VIRAL INFECTIONS INCLUDING SARS-COV-2 | GILEAD SCIENCES, INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| US-20230279014-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | GILEAD SCIENCES, INC. | 2023-09-07 | — | — | US | disclosed |
| EP-4134098-A1 | METHOD OF CANCER THERAPY | ONO Pharmaceutical Co., Ltd. (JP) | 2023-02-15 | — | — | EP | disclosed |
| EP-4134134-A1 | STING AGONISTIC COMPOUND | ONO Pharmaceutical Co., Ltd. (JP) | 2023-02-15 | — | — | EP | disclosed |
| US-5026758-A | Heat resistance, toughness | BAYER AKTIENGESELLSCHAFT (DE) | 1991-06-25 | — | — | US | disclosed |
| EP-0419927-A1 | Thermoplastic moulding compositions of polyalkylene terephthalate, specific barium sulfate, particulate graft polymers, and possibly reinforcing agents | BAYER AG (DE) | 1991-04-03 | — | — | EP | disclosed |
| EP-0416407-A1 | Thermoplastic moulding compositions of polycarbonate, polyalkylene terephthalate, specific barium sulfate, and possibly elastomers | BAYER AG (DE) | 1991-03-13 | — | — | EP | disclosed |
| EP-0371530-A1 | Process for manufacturing barium sulphate with a variable morphology | METALLGESELLSCHAFT Aktiengesellschaft (DE) | 1990-06-06 | — | — | EP | disclosed |
| EP-0335159-A1 | Thermoplastic moulding compositions | BAYER AG (DE) | 1989-10-04 | — | — | EP | disclosed |
| EP-0293622-A1 | Process for preparing barium sulphate having a chemically reactive surface | METALLGESELLSCHAFT AG (DE) | 1988-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230279014-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | HAVCR2, EIF2AK2, OAT | TSHR 4522/4885CETP 727/4885SRC 1829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.